| Literature DB >> 34511801 |
Shreya Das Adhikari1, Swagata Biswas2, Seema Mishra2, Vinod Kumar2, Sachidanand Jee Bharti2, Nishkarsh Gupta2, Rakesh Garg2, Sushma Bhatnagar2.
Abstract
OBJECTIVES: The availability of routine care for patients with cancer during the coronavirus disease 2019 (COVID-19) pandemic has become challenging, and the use of telemedicine can be promising in this area. The objective of the study is to evaluate the feasibility of telemedicine-based palliative interventions in cancer patients.Entities:
Keywords: Cancer; Coronavirus disease 2019; Palliative medicine; Patient satisfaction; Telemedicine
Year: 2021 PMID: 34511801 PMCID: PMC8428884 DOI: 10.25259/IJPC_45_21
Source DB: PubMed Journal: Indian J Palliat Care ISSN: 0973-1075
Characteristics of teleconsultation calls
| Patient demographics | Number of patients (%) Total = 547 | |
|---|---|---|
| Age | >18 years | 532 (97.26) |
| <18 years | 15 (2.74) | |
| Sex | Males | 263 (48) |
| Females | 284 (52) | |
| Residence | Delhi NCR | 233 (42.56) |
| Outside NCR | 314 (57.40) | |
| Educational qualification of person attending call | Illiterate | 12 (2.19) |
| Upto 5th standard | 27 (4.94) | |
| Upto 12th standard | 275 (50.27) | |
| Graduate and above | 233 (42.6) | |
|
|
| |
| Type of calls | Voice | 462 (84.46) |
| Video | 79 (14.44) | |
| Text | 4 (0.73) | |
| Number of Calls | Single | 420(76.78) |
| Multiple | 127(23.21) | |
| Duration of Calls (minutes) | <5 | 46(8.41) |
| 5-10 | 264(48.26) | |
| 10-15 | 203(37.11) | |
| >15 | 34(6.22) | |
| Timing of calls | 6am – 10am | 66 (12.07) |
| 10am – 2pm | 327 (59.79) | |
| 2pm – 8pm | 115 (21.02) | |
| 8pm – 6am | 39 (7.13) | |
|
| ||
|
|
|
|
| Duration of disease | <6months | 192(35.1) |
| 6months – 1 year | 239(43.7) | |
| >1 year | 116(21.2) | |
| Status of Disease | Under Evaluation | 54 (9.87) |
| Ongoing Treatment with Curative Intent | 288 (52.54) | |
| Cancer Survivor | 204 (37.3) | |
| Cancer Survivor | 4 (0.73) | |
| Type of Malignancy | Lung malignancy | 50 (9.14) |
| Gastrointestinal Malignancy | 64 (11.7) | |
| Hepatobiliary Malignancy | 56 (10.23) | |
| Gynaecological Malignancy | 45 (8.22) | |
| Bone and Soft Tissue Malignancy | 69 (12.61) | |
| Urogenital Malignancy | 31 (5.66) | |
| Breast Malignancy | 92 (16.82) | |
| Head and Neck Malignancy | 91 (16.64) | |
| Haematological Malignancy | 28 (5.18) | |
| Neuroendocrine Tumours | 14 (1.83) | |
| Carcinoma of Unknown Primary | 7 (1.28) | |
Figure 1:Reasons cited for utilising telemedicine.
Figure 2:Chief complaints of the patients addressed using teleconsultation.
Figure 3:Final advice given to the patients on teleconsultation.
Figure 4:Satisfaction score (4-point Likert scale) shows high satisfaction levels with telemedicine use.